Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor reverses diabetes in NOD mice

被引：0
|
作者：
Suarez-Pinzon, Wilma L.
Cembrowski, George S.
Rabinovitch, Alex
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A444 / A444
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis
    Min, Se Hee
    Yoon, Jeong-Hwa
    Hahn, Seokyung
    Cho, Young Min
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04) : 893 - 902
  • [32] Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor
    Boulton, David W.
    CLINICAL PHARMACOKINETICS, 2017, 56 (01) : 11 - 24
  • [33] Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management
    Yasuda, Takuma
    Harada, Norio
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (06) : 704 - 706
  • [34] Effect of Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin on Plasminogen Activator Inhibitor-1 in Patients With Diabetes Mellitus
    Tani, Shigemasa
    Takahashi, Atsuhiko
    Nagao, Ken
    Hirayama, Atsushi
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (04): : 454 - 460
  • [35] Dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid
    Reactions Weekly, 2021, 1861 (1) : 9 - 9
  • [36] Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
    Ahren, B.
    Schweizer, A.
    Dejager, S.
    Villhauer, E. B.
    Dunning, B. E.
    Foley, J. E.
    DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 775 - 783
  • [37] Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
    Kano, Yasuhiro
    Kato, Miyuki
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (34) : E1186 - E1187
  • [38] Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
    Mega, Cristina
    Teixeira-Lemos, Edite
    Fernandes, Rosa
    Reis, Flavio
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [39] Dipeptidyl peptidase-4 inhibitor-related renal disease
    Suenaga, Atsuhiko
    Sawa, Naoki
    Oba, Yuki
    Ikuma, Daisuke
    Sekine, Akinari
    Hasegawa, Eiko
    Mizuno, Hiroki
    Suwabe, Tatsuya
    Ikeda, Sara
    Tsujimoto, Tetsuro
    Kono, Kei
    Shintani-Domoto, Yukako
    Kinowaki, Keiichi
    Ohashi, Kenichi
    Miyazono, Motoaki
    Yamaguchi, Yutaka
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (10)
  • [40] Collagenous Colitis Possibly Associated with Dipeptidyl Peptidase-4 Inhibitor
    Takedomi, Hironobu
    Sakata, Yasuhisa
    Tomonaga, Michito
    Naruse, Naomi
    Yukimoto, Takahiro
    Akutagawa, Takashi
    Tsuruoka, Nanae
    Shimoda, Ryo
    Kido, Shinichi
    Esaki, Motohiro
    INTERNAL MEDICINE, 2022, 61 (18) : 2731 - 2734
12345